BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21143599)

  • 1. Synergistic activity of interleukin-17 and tumor necrosis factor-α enhances oxidative stress-mediated oligodendrocyte apoptosis.
    Paintlia MK; Paintlia AS; Singh AK; Singh I
    J Neurochem; 2011 Feb; 116(4):508-21. PubMed ID: 21143599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
    Paintlia AS; Paintlia MK; Singh AK; Singh I
    Glia; 2013 Sep; 61(9):1500-1517. PubMed ID: 23839981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
    De Nuccio C; Bernardo A; Cruciani C; De Simone R; Visentin S; Minghetti L
    Exp Neurol; 2015 Sep; 271():506-14. PubMed ID: 26210873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.
    Paintlia MK; Paintlia AS; Khan M; Singh I; Singh AK
    J Neurochem; 2008 May; 105(3):956-70. PubMed ID: 18205750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
    Zhang X; Haaf M; Todorich B; Grosstephan E; Schieremberg H; Surguladze N; Connor JR
    Glia; 2005 Nov; 52(3):199-208. PubMed ID: 15968631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes.
    Ladiwala U; Li H; Antel JP; Nalbantoglu J
    J Neurochem; 1999 Aug; 73(2):605-11. PubMed ID: 10428056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats.
    Mann SA; Versmold B; Marx R; Stahlhofen S; Dietzel ID; Heumann R; Berger R
    J Neuroinflammation; 2008 Sep; 5():39. PubMed ID: 18808689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture.
    Pang Y; Cai Z; Rhodes PG
    J Neurosci Res; 2005 Apr; 80(2):226-34. PubMed ID: 15765524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
    Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
    J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFbeta receptors.
    Marmur R; Kessler JA; Zhu G; Gokhan S; Mehler MF
    J Neurosci; 1998 Dec; 18(23):9800-11. PubMed ID: 9822739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development.
    Pang Y; Campbell L; Zheng B; Fan L; Cai Z; Rhodes P
    Neuroscience; 2010 Mar; 166(2):464-75. PubMed ID: 20035837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin promotes oligodendrocyte differentiation and their protection against TNF-α through the activation of the nuclear receptor PPAR-γ.
    Bernardo A; Plumitallo C; De Nuccio C; Visentin S; Minghetti L
    Sci Rep; 2021 Mar; 11(1):4952. PubMed ID: 33654147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors.
    Ness JK; Scaduto RC; Wood TL
    Glia; 2004 Apr; 46(2):183-94. PubMed ID: 15042585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.
    Luo F; Herrup K; Qi X; Yang Y
    Exp Neurol; 2017 Jun; 292():21-34. PubMed ID: 28238799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves.
    De Nuccio C; Bernardo A; De Simone R; Mancuso E; Magnaghi V; Visentin S; Minghetti L
    J Neuropathol Exp Neurol; 2011 Oct; 70(10):900-12. PubMed ID: 21937914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.
    Paintlia AS; Paintlia MK; Singh AK; Orak JK; Singh I
    Glia; 2010 Nov; 58(14):1669-85. PubMed ID: 20578043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis.
    Luyt K; Váradi A; Durant CF; Molnár E
    J Neurochem; 2006 Oct; 99(2):641-56. PubMed ID: 16836654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury.
    D'Souza SD; Alinauskas KA; Antel JP
    J Neurosci Res; 1996 Feb; 43(3):289-98. PubMed ID: 8714518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.
    Vela JM; Molina-Holgado E; Arévalo-Martín A; Almazán G; Guaza C
    Mol Cell Neurosci; 2002 Jul; 20(3):489-502. PubMed ID: 12139924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of BMP-7 against tumor necrosis factor α-induced oligodendrocyte apoptosis.
    Wang X; Xu JM; Wang YP; Yang L; Li ZJ
    Int J Dev Neurosci; 2016 Oct; 53():10-17. PubMed ID: 27224662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.